SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

TMC is trending as recent actions by NOAA to streamline deep-sea mining permits ignite speculation of a faster path to commercial recovery for U.S. companies. The community is highly bullish, viewing critical deep-sea minerals as a national security priority, and is actively discussing the potential for a short squeeze ahead of an upcoming Congressional hearing featuring TMC's CEO.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX), Mobileye, Accelerated Computing Systems and Graphics (AXG), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The NEX segment offers computing system solutions from inflexible fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Mobileye segment develops driving assistance and self-driving solutions. The AXG segment provides products and technologies designed to help customers solve the toughest computational problems. Its products include CPUs for high-performance computing and GPUs targeted for a range of workloads and platforms, from gaming and content creation on client devices to delivering media and gaming in the cloud, and the most demanding high-performance computing and AI workloads on supercomputers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968 and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is currently surging, fueled by recent analyst upgrades, substantial government support for its US-based foundries, and intense speculation around potential major partnerships. Community sentiment is sharply divided, with jubilant bulls celebrating significant gains and anticipating a massive turnaround, while others warn of an unsustainable rally ahead of its anticipated earnings report.

ProShares Trust - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

ProShares Ultra Bloomberg Natural Gas ($BOIL) is trending amid an extreme arctic cold front and polar vortex sweeping across the U.S., significantly driving up natural gas demand and futures prices. The community is actively discussing intense price volatility, the potential for a short squeeze, and the impact on natural gas storage levels, while also highlighting the inherent "widow maker" risks of leveraged natural gas ETFs.

MiMedx Group, Inc. is a therapeutic biologics company, which engages in the design, manufacture, and marketing of products, and tissue processing services. It serves the wound care, burn, surgical, orthopedic, spine, sports medicine, ophthalmic, and dental sectors of healthcare. Its biomaterial platform technologies include AmnioFix and EpiFix, a tissue allografts derived from amnion and chorion layers of human placental membrane, EpiCord and AmnioCord, a tissue allografts derived from umbilical cord tissue, and AmnioFill, a placental connective tissue matrix derived from the placental disc and other placental tissue. The company was founded on July 30, 1985 and is headquartered in Marietta, GA.

Mimedx Group Inc

MiMedx Group is trending amid significant community concern over upcoming CMS reimbursement changes set to impact high-average selling price wound care products in 2026. Discussions highlight widespread bearish sentiment, with many anticipating substantial revenue declines and raising allegations of past billing improprieties involving products like Celera and Emerge. This regulatory uncertainty compounds frustration over the company's declining stock performance and perceived lack of communication from management regarding strategic responses or buybacks.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is trending after a Neutron rocket Stage 1 tank rupture during qualification testing, sparking a polarized debate among investors. While bulls interpret this as a normal and necessary part of stress testing, highlighting the company's robust Electron launch record and significant defense contracts, bears are concerned about potential delays to the Neutron program and a possible stock correction.

ProShares Trust - ProShares UltraShort Bloomberg Natural Gas -2x Shares

ProShares UltraShort Bloomberg Natural Gas

KOLD is experiencing extreme volatility as natural gas prices surge due to forecasts of an intense Arctic freeze across the U.S. The community is actively discussing entry and exit points, keenly aware of the "widow maker" reputation of these leveraged ETFs amid dramatic price swings. Many are attempting to capitalize on the rapid moves, while others caution against the inherent risks of such instruments.

PAVmed, Inc. is a multi-product life sciences company, which engages in the innovation, development, acquisition, and commercialization of products that target unmet medical needs with large addressable market opportunities. Its products include Lucid Diagnostics and Veris Health. The company was founded by Lishan Aklog and Brian J. deGuzman on June 26, 2014 and is headquartered in New York, NY.

PAVmed Inc

PAVmed is currently trending following its subsidiary, Lucid Diagnostics, securing a contract with the U.S. Department of Veterans Affairs for its EsoGuard Esophageal DNA Test, significantly expanding access to esophageal precancer screening. This news has sparked considerable community excitement, with traders noting the stock's low float and discussing the potential for a substantial short squeeze, drawing comparisons to other recent explosive movers in the market.

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals is trending after presenting compelling Phase 1 clinical trial data for its eczema treatment, soquelitinib, which has fueled investor enthusiasm for its broader therapeutic potential. However, community sentiment is sharply divided between those anticipating further upside from this innovative science and others expressing deep concern over the company's valuation for a Phase 1 asset and the impact of significant share offerings.

Cipher Mining, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Mining Inc

Cipher Mining is trending due to its significant expansion into the AI/HPC data center sector, highlighted by an Ohio site acquisition and strategic deals with hyperscalers. The community is actively discussing CIFR's strategic pivot from solely Bitcoin mining, anticipating its role as a critical power backbone for the accelerating AI boom. This focus on infrastructure and substantial contracted revenue from major tech players fuels optimism amidst ongoing discussions about market volatility.

Under Armour, Inc. engages in the development, marketing, and distribution of branded performance apparel, footwear, and accessories for men, women, and youth. It operates through the following geographical segments: North America, EMEA, Asia-Pacific, Latin America, and Other. The company was founded by Kevin A. Plank in 1996 and is headquartered in Baltimore, MD.

Under Armour Inc - Ordinary Shares - Class C

Under Armour Inc Class C

Under Armour is trending due to significant institutional accumulation by major investors, including Fairfax Financial Holdings, which is seen as a strong vote of confidence in the brand's turnaround efforts. This aggressive buying, alongside considerable short interest, is fueling community discussion about a potential short squeeze and the company's perceived undervaluation. Investors are actively watching for signs of the strategic reset gaining traction amidst broader sector dynamics.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CFG Q4 Earnings Beat Estimates on NII & Fee Income Growth, Stock Up

Citizens Financial's results gain on the back of net interest income and fee growth. The stock gains nearly 2.8% in early trading.

Huntington Bancshares (NASDAQ:HBAN) Sets New 1-Year High - Time to Buy?

Huntington Bancshares (NASDAQ:HBAN) Reaches New 1-Year High - Here's Why...

HWC Q4 Earnings Beat Estimates on Fee Income & NII, Shares Dip

Hancock Whitney tops Q4 earnings estimates as loan growth and higher NII and non-interest income drive gains, even as expenses and credit provisions rise.

U.S. Bancorp Q4 Earnings Beat Estimates as NII & Fee Income Rise Y/Y

USB tops Q4 earnings estimates as net interest income and fee income rise year over year, aided by lower expenses and improved operating efficiency.

High Expenses & Lower Fee Income Likely to Hurt HBAN's Q4 Earnings

Huntington Bancshares is set to report Q4 and full-year results on Jan. 22, with higher expenses and weaker fee income likely to offset gains in loans and NII.

Jim Cramer Says Sell Super Micro Calls A European Chipmaker 'Cheap And Good'

Jim Cramer recommended selling Super Micro Computer Inc. and doesn't recommend Alkermes plc. Huntington Bancshares is 'terrific.' Smith & Nephew plc should be sold. Cramer also recommends buying...

Huntington Bancshares Incorporated $HBAN Shares Sold by Fjarde AP Fonden Fourth Swedish National Pension Fund

Fjarde AP Fonden Fourth Swedish National Pension Fund reduced its stake in shares of Huntington Bancshares Incorporated (NASDAQ:HBAN - Free Report) by 28.7% in the 3rd quarter, according to the...

MTB Q4 Earnings Beat Estimates on Higher NII & Fee Income, Stock Down

M&T Bank's Q4 results benefit from higher NII and fee income, though rising costs and an early share decline weigh on sentiment. 

PNC Financial Shares Gain on Q4 Earnings Beat & Record Revenues

PNC shares rally after Q4 EPS of $4.88 beat estimates, as record $6.1B revenues, higher NII and fees, and lower credit costs offset the rise in expenses.

First Horizon Shares Gain as Q4 Earnings Beat on Y/Y NII Growth

FHN shares rise after Q4 EPS beat estimates, fueled by year-over-year NII growth and a surge in non-interest income.

Huntington Bancshares, Inc. is a bank holding company, which engages in the provision of full-service commercial and consumer deposit, lending, and other banking services. It operates through Consumer and Regional Banking, and Commercial Banking. The Consumer and Regional Banking segment provides a wide array of financial products and services to consumer and business customers including deposits, lending, payments, mortgage banking, dealer financing, investment management, trust, brokerage, insurance, and other financial products and services. The Commercial Banking segment is involved in expertise through bankers, capabilities, and digital channels, and includes a comprehensive set of product offerings. The company was founded in 1866 and is headquartered in Columbus, OH.

Huntington Bancshares, Inc.

Up 10% or more

0% to up 9%

Down 1% to 9%

Down 10% or more

The S&P 500 enters 2026 after a strong run. What kind of return do you expect this year?

How will the S&amp;P 500 perform in 2026?

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	$0.33	--	--	N/A
Q3 '25	$0.37	$0.41	9.48%	BEAT
Q2 '25	$0.33	$0.34	1.75%	BEAT
Q1 '25	$0.31	$0.34	8.36%	BEAT
Q4 '24	$0.31	$0.34	8.90%	BEAT

HBAN
Huntington Bancshares, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest HBAN News

HBANHuntington Bancshares, Inc.